BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, January 6, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Appointments and advancements for Aug. 14, 2020

Aug. 14, 2020
New hires and promotions in the med-tech industry, including: Assure Holdings, Conformis, Myriad Genetics, Nephros, NMS Labs.
Read More

Other news to note for Aug. 14, 2020

Aug. 14, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Dr. Falk, JN Nova, Lumos, Merck, Prometheus, Revive.
Read More

In the clinic for Aug. 14, 2020

Aug. 14, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cortexyme, Imara, Lupin.
Read More

Financings for Aug. 14, 2020

Aug. 14, 2020
Biopharmas raising money in public or private financings, including: Acacia, Equillium, Oncology Venture, Optinose, PDS.
Read More

Appointments and advancements for Aug. 14, 2020

Aug. 14, 2020
New hires and promotions in the biopharma industry, including: Aditx, Novocure, Viacyte.
Read More

Regulatory actions for Aug. 13, 2020

Aug. 13, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: 4D Molecular Therapeutics, Bayer, Hyperfine, Inmode, Osprey Medical, Quidel, RapidAI, Spectronrx.
Read More

Other news to note for Aug. 13, 2020

Aug. 13, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Altitude Lab, Applied Stemcell, Apteryx, Baylor Genetics, Biocept, Bio-Infusions USA, BioUtah, Biosensors, E25bio, Epigenomics, Exact Sciences, G42 Healthcare, Medcrypt, Medisao, Miramedtech, Planet DDS, Recursion Pharmaceuticals, Royal Philips, Soliton, Stagebio, Sword Health, Tempucheck, Vivera Pharmaceuticals, Whoop.
Read More

Financings for Aug. 13, 2020

Aug. 13, 2020
Med-tech firms raising money in public or private financings, including: Assure Holdings.
Read More

Appointments and advancements for Aug. 13, 2020

Aug. 13, 2020
New hires and promotions in the med-tech industry, including: Ajax Health, Exactech, Omega Therapeutics, Transenterix.
Read More

Regulatory actions for Aug. 13, 2020

Aug. 13, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: 4D Molecular, Akeso, Antengene, Biomarin, Enzychem, Genentech, Hoth, Micurx, NS, Passage, Scholar Rock, TG.
Read More
Previous 1 2 … 1484 1485 1486 1487 1488 1489 1490 1491 1492 … 1729 1730 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 5, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 5, 2026.
  • Sickle cell illustration

    AND-017 increases RBC and hemoglobin in sickle cell disease

    BioWorld Science
    Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
  • 3D rendering of antibody drug conjugated with cytotoxic payload

    ADCs’ breakout 2025 and their still-unfinished potential

    BioWorld Science
    Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
  • Businessman, businesswoman handshake

    Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

    BioWorld
    Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing